Company: ILLRW
Filing Date: 2025-01-29
Form Type: 8-K
Source: 0001213900-25-007707
Chunk: 2

Company: Triller Group Inc.
Filing Date: 2025-01-29
Form: 8-K
Item: Item 3.02
Chunk 2
---
Item 3.02 Unregistered Sales of Equity Securities

The information contained
above in Item 1.01 is hereby incorporated by reference into this Item 3.02. Based in part upon the representations of the Purchaser in
the PIPE Purchase Agreement, the offering and sale of the PIPE Securities is exempt from registration under Section 4(a)(2) of the Securities
Act of 1933, as amended (the “Securities Act”), Rule 506 of Regulation D promulgated under the Securities Act, and
corresponding provisions of state securities or “blue sky” laws. The sale of the PIPE Securities by the Company in the Private
Placement has not been registered under the Securities Act or any state securities laws and the PIPE Securities may not be offered or
sold in the United States absent registration with the SEC or an applicable exemption from the registration requirements. The sale of
such securities does not involve a public offering and was made without general solicitation or general advertising. In the PIPE Purchase
Agreement, the Purchaser represented that it is an accredited investor, as such term is defined in Rule 501(a) of Regulation D under the
Securities Act, and it is acquiring the PIPE Securities for investment purposes only and not with a view to any resale, distribution or
other disposition of the PIPE Securities in violation of the United States federal securities laws.

Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Pursuant to the PIPE Purchase
Agreement, the Purchaser has the right to designate an individual to the board of directors of the Company (the “Board”).
In accordance with the terms of the PIPE Purchase Agreement, the Company has appointed Mr. Roger C. Kennedy, the Purchaser’s designee,
to the Board as a non-executive director, and member of each of the audit committee, remuneration committee and nomination committee
of the board. In connection with such appointment, the Company entered into a director indemnification agreement with Mr. Kennedy on
January 24, 2025 (the “Director Indemnification Agreement”), pursuant to which the Company agrees to hold harmless,
defend, and indemnify Mr. Kennedy to the fullest extent permitted by applicable law and the Company’s charter and bylaws, against,
among other things, liabilities and expenses incurred by him in connection with any proceeding arising out of his services as director,
subject to the exceptions and